ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 372474 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 372474; 2) Community: the network communities that were significantly associated with the response to NSC 372474; 3) Molecule: the relationships between components within communities and NSC 372474; 4) MDR: the compounds that were significantly associated with the NSC 372474.

NSC Compound Enrichment Correlation
NSC 639517 Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0423559437159354 0.60999202
NSC 669145 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- 0.0423559437159354 0.72146882
NSC 642316 ANTINEOPLASTIC-642316 0.0423559437159355 -0.045896916
NSC 666288 Null 0.0423559437159355 0.15407648
NSC 728073 Irinotecan hydrochloride 0.0423559437159355 0.099780846
NSC 733981 gamma-glutamyl-alpha-amino-beta-[[2-ethyl(5-fluoro-2'deoxyur idyl) N-methyl-N-(4-chlorobutyl)phosphoramidoyl]sulfonyl] propionyl-(R)-(-)-phenylglycine 0.0423559437159355 0.23084272
NSC 621888 Cyclopentanone, 2-[(dimethylamino)methyl]-, hydrochloride (9CI) 0.0457230037898003 0.661888
Total:59  Current:59    [First] [Prev] [Next] [Last]